VCP Scanner
ScreenerTechnicalBreakoutsThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistPricing
ScreenerTechnical ScannerBreakoutsThemes
Earnings
WatchlistPricing
Ctrl K
CL
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
CLColgate-Palmolive Company
$93.00$74.4B
Overview & Verdict
OverviewVisualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCLBalance Sheet

Colgate-Palmolive Company (CL) Balance Sheet

30Y historyFree accessUpdated daily

The balance sheet shows extreme leverage with debt-to-equity at 13.9 and equity of only $236M, despite retained earnings of $27.1B, reflecting massive share repurchases that have eroded the equity base.

CL Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Total Current Assets6.31B5.71B5.32B5.28B5.11B4.4B4.34B4.18B3.79B4.64B4.34B4.38B4.86B4.82B4.56B4.4B3.73B3.81B3.71B3.62B3.3B2.76B2.74B2.5B2.23B2.2B2.35B2.35B2.24B2.2B2.37B
Cash & Short-Term Investments1.37B1.29B1.26B966M775M832M888M883M726M1.53B1.31B970M1.09B962M884M878M490M600M555M428.7M489.5M340.7M319.6M265.3M167.9M172.7M212.5M235.2M181.7M183.1M248.2M
Cash Only1.37B1.29B1.1B966M775M832M888M883M726M1.53B1.31B970M1.09B962M884M878M490M600M554.9M428.7M489.5M340.7M319.6M265.3M167.9M172.7M206.6M199.6M181.7M183.1M248.2M
Short-Term Investments00160M000000000000000000000005.9M35.6M000
Accounts Receivable1.96B1.68B1.52B1.59B1.5B1.3B1.26B1.44B1.4B1.48B1.41B1.43B1.55B1.64B1.67B1.68B1.61B1.63B1.59B1.68B1.52B1.31B1.32B1.22B1.15B1.12B1.2B1.1B1.09B1.04B1.06B
Days Sales Outstanding31.793027.6229.7530.5527.1728.0133.4932.8734.9633.8932.4832.7934.2835.6336.5337.7638.7237.9144.4945.4341.9445.5245.0544.9843.5546.6344.0644.1741.8144.41
Inventory2.18B2.03B1.99B1.93B2.07B1.69B1.67B1.4B1.25B1.22B1.17B1.18B1.38B1.43B1.36B1.33B1.22B1.21B1.2B1.17B1.01B855.8M845.5M718.3M671.7M677M686.6M783.7M746M728.4M770.7M
Days Inventory Outstanding92.1291.2290.7186.0296.8486.6493.479.6471.9972.6970.564.6370.3372.2169.568.0469.8470.0165.5772.1768.7261.1664.8658.8458.0458.3258.7573.6568.7664.1968.03
Other Current Assets795M714M553M793M760M576M513M456M417M403M441M807M840M799M639M522M408M375M366.1M338.1M279.9M251.2M254.9M290.5M243.1M228.8M252.7M235.1M231.6M247.6M289M
Total Non-Current Assets10.48B10.62B10.73B11.11B10.62B10.64B11.58B10.86B8.37B8.04B7.79B7.57B8.6B9.05B8.84B8.32B7.44B7.32B6.27B6.49B5.84B5.75B5.93B4.98B4.86B4.78B4.91B5.07B5.44B5.34B5.53B
Property, Plant & Equipment4.64B4.66B4.42B4.58B4.31B3.73B3.72B3.75B3.88B4.07B3.84B3.8B4.08B4.08B3.84B3.67B3.69B3.52B3.12B3.02B2.7B2.54B2.65B2.54B2.49B2.51B2.53B2.55B2.59B2.44B2.43B
Fixed Asset Turnover4.56x4.37x4.55x4.25x4.17x4.67x4.43x4.18x4.01x3.80x3.96x4.22x4.23x4.27x4.45x4.56x4.21x4.36x4.91x4.57x4.54x4.48x4.00x3.90x3.73x3.75x3.70x3.57x3.47x3.71x3.60x
Goodwill3.1B3.12B3.27B3.41B3.35B3.28B3.82B3.51B2.53B2.22B2.11B2.1B2.31B2.47B2.5B2.66B2.36B2.3B2.15B2.27B2.08B1.85B1.89B00000000
Intangible Assets1.5B1.54B1.76B1.89B1.92B2.46B2.89B2.67B1.64B1.34B1.31B1.35B1.41B1.5B1.5B1.34B831M821M833.5M844.8M831.1M783.2M832.4M1.9B1.79B1.9B2.1B2.19B2.52B2.59B2.72B
Long-Term Investments0081M0000000000000000000000000000
Other Non-Current Assets1.03B1.1B1B1.02B904M974M857M753M168M218M224M239M720M924M905M541M556M685M164M361.5M228M577M561.2M543.1M576.5M363.9M280.4M331.8M327M315.9M379.9M
Total Assets16.79B16.33B16.05B16.39B15.73B15.04B15.92B15.03B12.16B12.68B12.12B11.96B13.46B13.88B13.39B12.72B11.17B11.13B9.98B10.11B9.14B8.51B8.67B7.48B7.09B6.98B7.25B7.42B7.69B7.54B7.9B
Asset Turnover1.25x1.25x1.25x1.19x1.14x1.16x1.03x1.04x1.28x1.22x1.25x1.34x1.28x1.26x1.28x1.32x1.39x1.38x1.54x1.36x1.34x1.34x1.22x1.32x1.31x1.35x1.29x1.23x1.17x1.20x1.11x
Asset Growth %2.06%1.77%-2.12%4.21%4.59%-5.53%5.89%23.62%-4.06%4.56%1.38%-11.15%-3.01%3.6%5.27%13.89%0.34%11.57%-1.31%10.66%7.42%-1.91%15.97%5.53%1.47%-3.69%-2.3%-3.41%1.94%-4.59%3.39%
Total Current Liabilities6.15B5.74B5.76B4.74B4B4.05B4.4B4.04B3.34B3.41B3.31B3.53B3.95B4.58B3.74B3.72B3.73B3.6B2.95B3.16B3.47B2.74B2.73B2.45B2.15B2.12B2.24B2.27B2.11B1.96B1.9B
Accounts Payable2.12B01.8B1.7B1.55B1.48B1.39B1.24B1.22B1.21B1.12B1.11B1.23B1.34B1.29B1.24B1.17B1.17B1.06B1.07B1.04B876.1M864.4M753.6M728.3M678.1M738.9M764.8M726.1M716.9M751.7M
Days Payables Outstanding66.58-82.475.5372.4275.7377.7770.3770.3772.1567.6760.862.6568.0565.6863.7866.5967.8758.1265.7570.8562.6166.3161.7362.9358.4263.2371.8866.9363.1866.36
Short-Term Debt34M0660M330M25M51M267M514M12M11M13M302M504M908M304M380M609M361M198M294M950.8M528.2M585.6M418M393.1M427.1M441.3M546.2M456.9M336.7M282.7M
Deferred Revenue (Current)0000000000000000000000000000000
Other Current Liabilities05.74B116M122M97M93M182M70M93M101M84M79M94M105M96M90M00000000000962.5M931.4M905.9M869.9M
Current Ratio1.03x1.00x0.92x1.11x1.28x1.09x0.99x1.03x1.14x1.36x1.31x1.24x1.23x1.05x1.22x1.18x1.00x1.06x1.26x1.14x0.95x1.01x1.00x1.02x1.04x1.04x1.05x1.04x1.06x1.12x1.25x
Quick Ratio0.67x0.64x0.58x0.71x0.76x0.67x0.61x0.69x0.76x1.00x0.96x0.91x0.88x0.74x0.85x0.83x0.67x0.72x0.85x0.77x0.66x0.69x0.69x0.73x0.72x0.72x0.74x0.69x0.71x0.75x0.84x
Cash Conversion Cycle57.33-35.9340.2554.9738.0843.6442.7734.4935.4936.7236.3240.4738.4339.4540.7941.0140.8645.3650.9143.340.4844.0742.1640.0943.4642.1545.844642.8246.08
Total Non-Current Liabilities10.08B10.23B9.74B10.7B10.92B10.02B10.41B10.44B8.62B9.03B8.8B8.45B8.13B6.87B7.27B6.47B4.63B4.28B4.98B4.55B4.26B4.41B4.7B4.15B4.59B4.01B3.54B3.32B3.49B3.4B3.96B
Long-Term Debt7.82B7.99B7.29B8.22B8.74B7.19B7.33B7.33B6.35B6.57B6.52B6.25B5.64B4.75B4.93B4.43B2.81B2.82B3.59B3.22B2.72B2.92B3.09B2.68B3.21B2.81B2.54B2.24B2.3B2.34B2.79B
Capital Lease Obligations00456M420M397M451M476M491M00000000005.7M000000000000
Deferred Tax Liabilities703M0343M361M383M395M426M507M235M204M246M233M261M444M293M252M108M82M81.9M264.1M309.9M554.7M509.6M456M488.8M480.6M447.3M398.6M448M284.5M234.3M
Other Non-Current Liabilities2.05B2.24B1.66B1.7B1.4B1.98B2.18B2.11B2.03B2.25B2.04B1.97B2.22B1.68B2.05B1.78B1.7B1.38B1.51B1.07B1.23B941.3M836.7M1.01B1.38B722.3M555.9M674M736.6M775.8M942M
Total Liabilities16.22B15.96B15.5B15.44B14.93B14.07B14.82B14.48B11.96B12.43B12.11B12B12.07B11.34B11B10.18B8.36B7.88B8.06B7.72B7.73B7.16B7.17B6.59B6.74B6.14B5.78B5.59B5.6B5.36B5.87B
Total Debt7.86B7.99B8.51B9.06B9.27B7.83B8.21B8.48B6.37B6.58B6.53B6.55B6.15B5.66B5.23B4.81B3.42B3.18B3.78B3.52B3.67B3.45B3.68B3.1B3.6B3.24B2.98B2.79B2.76B2.68B3.07B
Net Debt6.49B6.7B7.42B8.1B8.5B7B7.33B7.6B5.64B5.04B5.22B5.58B5.06B4.7B4.35B3.93B2.93B2.58B3.23B3.09B3.18B3.11B3.36B2.84B3.44B3.07B2.77B2.59B2.58B2.49B2.82B
Debt / Equity13.88x21.88x15.65x9.47x11.50x8.07x7.46x15.20x32.31x27.07x384.29x-4.44x2.23x2.19x1.89x1.22x0.98x1.97x1.47x2.60x2.55x2.44x3.50x10.29x3.83x2.03x1.52x1.32x1.23x1.51x
Debt / EBITDA1.63x1.60x1.71x1.93x2.24x1.76x1.85x1.98x1.46x1.47x1.48x1.48x1.33x1.24x1.18x1.12x0.83x0.78x1.03x1.07x1.27x1.28x1.45x1.25x1.56x1.47x1.45x1.41x1.52x1.60x1.96x
Net Debt / EBITDA1.34x1.35x1.49x1.72x2.06x1.58x1.65x1.78x1.29x1.12x1.19x1.26x1.09x1.03x0.98x0.92x0.71x0.63x0.88x0.94x1.10x1.15x1.33x1.14x1.49x1.40x1.35x1.31x1.42x1.49x1.81x
Interest Coverage12.53x12.46x14.55x12.82x16.93x27.38x23.79x18.19x18.95x23.79x26.09x21.77x28.18x31.73x49.43x66.33x53.77x41.20x29.46x16.39x13.36x15.98x17.57x--0.91x-----
Total Equity566M365M544M957M806M971M1.1B558M197M243M17M-44M1.39B2.54B2.39B2.54B2.82B3.26B1.92B2.4B1.41B1.35B1.51B887.1M350.3M846.4M1.47B1.83B2.09B2.18B2.03B
Equity Growth %-64.71%-32.9%-43.16%18.73%-16.99%-11.81%97.31%183.25%-18.93%1329.41%138.64%-103.18%-45.39%6.11%-5.94%-9.8%-13.51%69.45%-19.78%69.83%4.5%-10.38%69.81%153.24%-58.61%-42.35%-19.94%-12.08%-4.27%7.1%21.09%
Book Value per Share0.700.450.661.150.961.141.280.650.230.270.02-0.051.502.702.492.582.763.101.802.241.311.241.350.780.300.711.201.471.641.711.62
Total Shareholders' Equity236M54M212M609M401M609M743M117M-102M-60M-243M-299M1.15B2.31B2.19B2.38B2.67B3.12B1.92B2.29B1.41B1.35B1.25B887.1M350.3M846.4M1.47B1.83B2.09B2.18B2.03B
Common Stock1.47B1.47B1.47B1.47B1.47B1.47B1.47B1.47B1.47B1.47B1.47B1.47B1.47B1.47B733M733M733M733M732.9M732.9M732.9M732.9M732.9M732.9M732.9M732.9M732.9M732.9M000
Retained Earnings27.09B26.59B26.14B25.29B24.57B24.35B23.7B22.5B21.61B20.53B19.92B18.86B18.83B17.95B16.95B15.65B14.33B13.16B11.76B10.63B9.64B8.97B8.22B7.43B6.52B5.64B4.89B4.21B3.64B3.14B2.73B
Treasury Stock-28.93B-28.45B-27.36B-26.02B-25.13B-24.09B-23.05B-22.06B-21.2B-20.18B-19.14B-18.1B-16.86B-15.63B-14.39B-12.81B-11.3B-10.48B-9.7B-8.9B-8.07B-7.58B-6.97B-6.5B-6.15B-5.2B-4.04B-3.06B000
Accumulated OCI-3.82B-3.88B-4.22B-3.94B-4.05B-4.39B-4.34B-4.27B-4.19B-3.85B-4.18B-3.95B-3.51B-2.45B-2.62B-2.48B-2.12B-2.1B-2.48B-1.89B-2.33B-2.09B-2.11B-2.2B-2.21B-1.84B-1.61B-1.48B-1.54B-1.36B-1.4B
Minority Interest330M311M332M348M405M362M358M441M299M303M260M255M240M231M201M166M142M141M0109.9M00261M00000000

Key Metrics

Growth RegimeStable
ProfitabilityModerate
Balance SheetStrained
Cash FlowStable
Top Statement Risk

FX and margin compression

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Equity Erosion Amid Stable Assets

Total assets have remained near $16.8B over the past year, but equity has collapsed from $856M in 2025Q3 to $236M in 2026Q2, reflecting persistent share repurchases and dividend payouts exceeding earnings, as per quarterly filings.

The balance sheet is not expanding; rather, it is being hollowed out from within. While total assets have stayed flat, the equity base has shrunk by over 70% in four quarters, indicating that capital returns are being funded by debt and retained earnings depletion. This trend suggests that the company's financial flexibility is narrowing, and any adverse shock could quickly erode the already thin equity cushion.

Leverage Spikes as Equity Vanishes

Debt-to-equity has surged from 6.8 in 2025Q3 to 13.9 in 2026Q2, with total debt at $7.9B against equity of just $236M, according to the latest balance sheet data.

The dramatic rise in leverage is not due to increased borrowing but rather the denominator effect of shrinking equity. With debt levels relatively stable around $8B, the D/E ratio is now a function of equity depletion, which may overstate true credit risk. However, the thin equity base provides little buffer for asset write-downs or unexpected losses, and the company's ability to absorb shocks is increasingly reliant on its cash flow generation rather than balance sheet strength.

Asset Mix Signals Shift to Intangibles

Goodwill has declined from $3.7B in 2025Q3 to $3.1B in 2026Q2, while PPE has remained stable at $4.6B, indicating a potential impairment or divestiture, as per reported figures.

The reduction in goodwill suggests that the company may have taken an impairment charge or sold a business, which could indicate that prior acquisitions are not performing as expected. Meanwhile, the stable PPE suggests ongoing investment in fixed assets, but the overall asset base is not growing, implying a mature business with limited expansion. The mix of intangibles and fixed assets remains balanced, but the decline in goodwill warrants monitoring for further write-downs.

Retained Earnings Mask Equity Decline

Retained earnings have grown from $25.2B in 2024Q1 to $27.1B in 2026Q2, yet total equity has fallen to just $236M, highlighting the impact of massive share repurchases, as shown in the balance sheet.

The accumulation of retained earnings indicates profitable operations, but the equity base is being systematically reduced through buybacks and dividends that exceed net income. This strategy boosts per-share metrics but leaves the balance sheet with minimal equity, increasing financial risk. The negative equity trend, if continued, could lead to a negative book value, which may concern creditors and rating agencies despite strong cash flow.

Liquidity Cushion Thin but Stable

The current ratio has improved from 0.85 in 2025Q1 to 1.03 in 2026Q2, with cash at $1.4B, providing a modest buffer against short-term obligations, based on quarterly data.

While the current ratio has crossed above 1.0, indicating that current assets now exceed current liabilities, the absolute cash position of $1.4B is relatively small compared to total debt of $7.9B. This suggests that the company relies on ongoing cash flow to meet obligations rather than a large liquidity reserve. The improvement in the current ratio is positive, but the thin cash buffer leaves little room for unexpected cash needs without tapping credit lines.

Negative Equity Looms as Hidden Risk

With equity at just $236M and retained earnings at $27.1B, the balance sheet is one large buyback away from negative equity, a distortion not captured by headline leverage ratios, as per the latest 10-Q.

The company's aggressive capital return program has driven equity to near zero, which could trigger debt covenant issues or rating downgrades if not managed carefully. While the business generates strong cash flow, the balance sheet is becoming increasingly fragile, and any significant write-down or earnings miss could push equity negative. Investors should monitor the pace of buybacks and the company's commitment to maintaining a positive equity position.

CL — Frequently Asked Questions

Quick answers to the most common questions about buying CL stock.

What are the total assets of Colgate-Palmolive Company (CL)?

As of 2025, Colgate-Palmolive Company (CL) had total assets of $16.33B including $5.71B in current assets.

How much debt does Colgate-Palmolive Company (CL) have?

Colgate-Palmolive Company (CL) carries total debt of $7.99B, offset by $1.29B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Colgate-Palmolive Company?

Colgate-Palmolive Company (CL) has total shareholders' equity (book value) of $54.0M ($0.45 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Colgate-Palmolive Company's current ratio and liquidity?

Colgate-Palmolive Company (CL) reported a current ratio of 1.00x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.